|
1
|
Khalil Ibrahim A: Trends of adult primary
malignant renal tumors over 6 years. Pak J Med Sci. 29:1385–1388.
2013.PubMed/NCBI
|
|
2
|
Zhai W, Zhu R, Ma J, Gong D, Zhang H,
Zhang J, Chen Y, Huang Y, Zheng J and Xue W: A positive
feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3
signaling promotes proliferation and metastasis of clear cell renal
cell carcinoma. Mol Cancer. 18:812019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Sun K, Zheng R, Zeng H, Zhang S,
Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality
in China, 2014. Chin J Cancer Res. 30:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wong MCS, Goggins WB, Yip BHK, Fung FDH,
Leung C, Fang Y, Wong SYS and Ng CF: Incidence and mortality of
kidney cancer: Temporal patterns and global trends in 39 countries.
Sci Rep. 7:156982017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ravaud A, Motzer RJ, Pandha HS, George DJ,
Pantuck AJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, et
al: Adjuvant sunitinib in high-risk renal-cell carcinoma after
nephrectomy. N Engl J Med. 375:2246–2254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Frank I, Blute ML, Cheville JC, Lohse CM,
Weaver AL, Leibovich BC and Zincke H: A multifactorial
postoperative surveillance model for patients with surgically
treated clear cell renal cell carcinoma. J Urol. 170:2225–2232.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patard JJ, Kim HL, Lam JS, Dorey FJ,
Pantuck AJ, Zisman A, Ficarra V, Han KR, Cindolo L, De La Taille A,
et al: Use of the University of California Los Angeles integrated
staging system to predict survival in renal cell carcinoma: An
international multicenter study. J Clin Oncol. 22:3316–3322. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sorbellini M, Kattan MW, Snyder ME, Reuter
V, Motzer R, Goetzl M, McKiernan J and Russo P: A postoperative
prognostic nomogram predicting recurrence for patients with
conventional clear cell renal cell carcinoma. J Urol. 173:48–51.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calvo E, Schmidinger M, Heng DY, Grünwald
V and Escudier B: Improvement in survival end points of patients
with metastatic renal cell carcinoma through sequential targeted
therapy. Cancer Treat Rev. 50:109–117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Z, Zhu R and Zheng J, Chen C, Huang
C, Ma J, Xu C, Zhai W and Zheng J: Cryptotanshinone inhibits
proliferation yet induces apoptosis by suppressing STAT3 signals in
renal cell carcinoma. Oncotarget. 8:50023–50033. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Ho G, Zhang JJ, Nieuwenhuijsen B,
Edris W, Chanda PK and Young KH: Regulator of G protein signaling
Z1 (RGSZ1) interacts with Galpha i subunits and regulates Galpha
i-mediated cell signaling. J Biol Chem. 277:48325–48332. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Vries L, Elenko E, Hubler L, Jones TL
and Farquhar MG: GAIP is membrane-anchored by palmitoylation and
interacts with the activated (GTP-bound) form of G alpha i
subunits. Proc Natl Acad Sci USA. 93:15203–15208. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nunn C, Mao H, Chidiac P and Albert PR:
RGS17/RGSZ2 and the RZ/A family of regulators of G-protein
signaling. Semin Cell Dev Biol. 17:390–399. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Ducret A, Tu Y, Kozasa T,
Aebersold R and Ross EM: RGSZ1, a Gz-selective RGS protein in
brain. Structure, membrane association, regulation by Galphaz
phosphorylation, and relationship to a Gz gtpase-activating protein
subfamily. J Biol Chem. 273:26014–26025. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang G, He X and Wei XL: lncRNA NEAT1
promotes cell proliferation and invasion by regulating
miR-365/RGS20 in oral squamous cell carcinoma. Oncol Rep.
39:1948–1956. 2018.PubMed/NCBI
|
|
18
|
Riker AI, Enkemann SA, Fodstad O, Liu S,
Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, et al: The
gene expression profiles of primary and metastatic melanoma yields
a transition point of tumor progression and metastasis. BMC Med
Genomics. 1:132008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Q, Jin W, Cai Y, Yang F, Chen E, Ye D,
Wang Q and Guan X: Regulator of G protein signaling 20 correlates
with clinicopathological features and prognosis in triple-negative
breast cancer. Biochem Biophys Res Commun. 485:693–697. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li G, Wang M, Ren L, Li H, Liu Q, Ouyang
Y, He L and Li F: Regulator of G protein signaling 20 promotes
proliferation and migration in bladder cancer via NF-κB signaling.
Biomed Pharmacother. 117:1091122019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang L, Lee MM, Leung MM and Wong YH:
Regulator of G protein signaling 20 enhances cancer cell
aggregation, migration, invasion and adhesion. Cell Signal.
28:1663–1672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Hu L, Liu Y, Huang L, Mu Y, Cai X
and Weng C: DDX19A senses viral RNA and mediates NLRP3-dependent
inflammasome activation. J Immunol. 195:5732–5749. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao X, Hu W, Zhang J, Huang C, Zhao H and
Yao X: Application of cAMP-dependent catalytic subunit β (PRKACB)
low expression in predicting worse overall survival: A potential
therapeutic target for colorectal carcinoma. J Cancer.
11:4841–4850. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Subramanian A, Kuehn H, Gould J, Tamayo P
and Mesirov JP: GSEA-P: A desktop application for gene set
enrichment analysis. Bioinformatics. 23:3251–3253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen H, Xu J, Hong J, Tang R, Zhang X and
Fang JY: Long noncoding RNA profiles identify five distinct
molecular subtypes of colorectal cancer with clinical relevance.
Mol Oncol. 8:1393–1403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kapoor A, Yao W, Ying H, Hua S, Liewen A,
Wang Q, Zhong Y, Wu CJ, Sadanandam A, Hu B, et al: Yap1 activation
enables bypass of oncogenic kras addiction in pancreatic cancer.
Cell. 179:12392019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu ZY, Zhao M, Chen W, Li K, Qin F, Xiang
WW, Sun Y, Wei J, Yuan LQ, Li SK and Lin SH: Analysis of prognostic
genes in the tumor microenvironment of lung adenocarcinoma. PeerJ.
8:e95302020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan Q, Sun N, Zheng J, Wang Y, Yan X, Mai
W, Liao Y and Chen X: Prognostic and immunological role of FUN14
domain containing 1 in pan-cancer: Friend or foe? Front Oncol.
9:15022020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hurst JH and Hooks SB: Regulator of
G-protein signaling (RGS) proteins in cancer biology. Biochem
Pharmacol. 78:1289–1297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hurst JH, Mendpara N and Hooks SB:
Regulator of G-protein signalling expression and function in
ovarian cancer cell lines. Cell Mol Biol Lett. 14:153–174. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
James MA, Lu Y, Liu Y, Vikis HG and You M:
RGS17, an overexpressed gene in human lung and prostate cancer,
induces tumor cell proliferation through the cyclic AMP-PKA-CREB
pathway. Cancer Res. 69:2108–2116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wiechec E, Overgaard J and Hansen LL: A
fragile site within the HPC1 region at 1q25.3 affecting RGS16,
RGSL1, and RGSL2 in human breast carcinomas. Genes Chromosomes
Cancer. 47:766–780. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang G, Yu H and Kirschner MW: The
checkpoint protein MAD2 and the mitotic regulator CDC20 form a
ternary complex with the anaphase-promoting complex to control
anaphase initiation. Genes Dev. 12:1871–1883. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Brown NR, Lowe ED, Petri E, Skamnaki V,
Antrobus R and Johnson LN: Cyclin B and cyclin A confer different
substrate recognition properties on CDK2. Cell Cycle. 6:1350–1359.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zou H, McGarry TJ, Bernal T and Kirschner
MW: Identification of a vertebrate sister-chromatid separation
inhibitor involved in transformation and tumorigenesis. Science.
285:418–422. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rajurkar M, Dang K, Fernandez-Barrena MG,
Liu X, Fernandez-Zapico ME, Lewis BC and Mao J: IKBKE is required
during KRAS-induced pancreatic tumorigenesis. Cancer Res.
77:320–329. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang W, Qu Y, Tan B, Jia Y, Wang N, Hu P
and Wang J: Prognostic significance of preoperative IKBKE
expression in esophageal squamous cell carcinoma. Onco Targets
Ther. 11:1305–1314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang X, Teng F, Lu J, Mu D, Zhang J and Yu
J: Expression and prognostic role of IKBKE and TBK1 in stage I
non-small cell lung cancer. Cancer Manag Res. 11:6593–6602. 2019.
View Article : Google Scholar : PubMed/NCBI
|
